Amedy Technical Institute, Duhok Polytechnic University, Kurdistan Region, Iraq; Department of Medical Microbiology, College of Medicine, University of Duhok, Kurdistan Region, Iraq.
Department of Internal Medicine, Azadi Teaching Hospital, College of Pharmacy, University of Duhok, Kurdistan Region, Iraq.
Int J Infect Dis. 2020 Jul;96:97-104. doi: 10.1016/j.ijid.2020.03.067. Epub 2020 Mar 31.
The objectives were to estimate the prevalence of latent tuberculosis infection (LTBI) among household contacts (HHCs) with active TB patients, and to identify their risk factors.
A prospective, cross sectional study was conducted from May to October 2018. All HHCs with active TB cases were included. The subjects underwent two tests: Quantiferon TB-Gold plus assay (QFT-Plus) and tuberculin skin test (TST). Data were analyzed using the Statistical Package for Social Sciences 25.
Among 521 HHCs, 101 (24.05%) revealed positive TST and 80 (19.85%) positive QFT-Plus. The significant risk factors associated with positive TST individuals were ≥ 15 years, immunosuppressive therapy, and pulmonary TB (PTB) patients; whereas, those with QFT-Plus positive were ≥ 45 years, alcohol consumption, and immunosuppressive therapy. The concordance rate among 309 individuals who performed both tests was 0.88 %; the kappa value showed good agreement (k = 0.679) and significant correlation (P < 0.001).
The overall rate of LTBI was intermediate. Screening of LTBI should be routine among HHCs, regardless of the site of the disease. Age ≥ 15 years, alcoholics, immunosuppressive therapy, and PTB were potential risk factors. There was a good concordance between TST and QFT-Plus. A QFT-Plus can overcome the limitation of a BCG vaccinated individual, especially in early life.
本研究旨在评估活动性肺结核(TB)患者家庭接触者(HHCs)中潜伏性结核感染(LTBI)的患病率,并确定其危险因素。
本前瞻性、横断面研究于 2018 年 5 月至 10 月进行。所有活动性 TB 病例的 HHCs 均纳入研究。受试者接受两种检测:QuantiFERON-TB Gold plus 检测(QFT-Plus)和结核菌素皮肤试验(TST)。采用社会科学统计软件包 25 进行数据分析。
在 521 名 HHCs 中,101 名(24.05%)TST 阳性,80 名(19.85%)QFT-Plus 阳性。与 TST 阳性个体相关的显著危险因素为年龄≥15 岁、免疫抑制治疗和肺结核(PTB)患者;而 QFT-Plus 阳性个体的危险因素为年龄≥45 岁、饮酒和免疫抑制治疗。对 309 名同时进行两项检测的个体进行一致性分析,其符合率为 0.88%;kappa 值显示一致性良好(k=0.679)且相关性显著(P<0.001)。
LTBI 的总体发生率处于中等水平。无论疾病部位如何,均应常规筛查 LTBI。年龄≥15 岁、酗酒者、免疫抑制治疗和 PTB 是潜在的危险因素。TST 和 QFT-Plus 之间具有良好的一致性。QFT-Plus 可以克服 BCG 接种个体的局限性,尤其是在生命早期。